文献速递关节外科

髌股关节置换翻修为全膝关节置换后的再次翻修风险如何?来自大型国家关节登记系统的482例分析

What Is the Risk of Repeat Revision When Patellofemoral Replacement Is Revised to TKA? An Analysis of 482 Cases From a Large National Arthroplasty Registry.
PubMed 文献 · Clin Orthop Relat Res · 2019-01-01

基于澳大利亚骨科协会关节置换登记系统截至2016年12月31日的数据,17年间3251例髌股关节置换(PFR)中有482例翻修为全膝关节置换(TKA)。翻修的主要原因为疾病进展(56%)、松动(17%)和疼痛(12%);翻修TKA的假体约束水平(后交叉韧带保留型与后交叉韧带替代型)及是否更换髌骨组件与再次翻修风险无关;PFR翻修为TKA后再次翻修风险高于初次TKA翻修风险(HR 2.39),但低于翻修TKA后再次翻修风险(HR 0.60)。

要点

  • PFR翻修为TKA的主要原因为疾病进展(56%)、松动(17%)和疼痛(12%)。
  • PFR翻修为TKA后再次翻修风险高于初次TKA翻修风险(HR 2.39 [1.77-3.24];p < 0.001)。
  • PFR翻修为TKA后再次翻修风险低于翻修TKA后再次翻修风险(HR 0.60 [0.43-0.81];p = 0.001)。

核心结论

  • PFR翻修时选用后交叉韧带保留型或后交叉韧带替代型TKA,以及是否更换髌骨组件,均不改变再次翻修风险。
  • PFR翻修为TKA后再次翻修风险远高于初次TKA的翻修风险,且仅分析2005年以来使用的假体时该结果不变。
  • 当PFR用于治疗孤立性髌股关节骨关节炎时,应告知患者原手术翻修率高,且TKA术后翻修率也高。
  • 作者认为,关于这些手术功能结局的进一步研究可能有助于阐明PFR及其后续翻修的价值。

研究设计与样本

  • 数据来自澳大利亚骨科协会关节置换登记系统,截至2016年12月31日,纳入PFR后行TKA翻修的手术。
  • 因感染进行的翻修可能为分期手术并导致后续计划手术,故在翻修分析中排除。
  • 17年研究期间共有3251例PFR,其中482例翻修为TKA。
  • 采用Kaplan-Meier生存估计计算PFR翻修为TKA后的第二次翻修风险,并与初次TKA后第一次翻修风险及翻修TKA后第二次翻修风险比较。
  • 采用Cox比例风险模型的风险比(HR)比较PFR翻修时不同假体约束水平(后交叉韧带保留型与后交叉韧带替代型)的第二次翻修率。

主要发现

  • PFR翻修为TKA的主要原因为疾病进展(56%)、松动(17%)和疼痛(12%)。
  • 在可分析的数据中,PFR翻修为后交叉韧带保留型TKA与后交叉韧带替代型TKA的第二次翻修风险无差异(HR 1.24 [0.65-2.36];p = 0.512)。
  • 204例(42%)PFR翻修为TKA时更换了髌骨组件;更换与不更换髌骨组件的第二次翻修率无差异(HR 1.01 [0.55-1.85];p = 0.964)。
  • 排除2005年前停用的旧假体后,总体再次翻修风险无变化。
  • PFR翻修为TKA后第二次翻修风险高于TKA第一次翻修风险(HR 2.39 [1.77-3.24];p < 0.001),但低于翻修TKA后第二次翻修风险(HR 0.60 [0.43-0.81];p = 0.001)。

临床怎么用

  • 当PFR用于治疗孤立性髌股关节骨关节炎时,应告知患者原手术翻修率高,且TKA术后翻修率也高。
  • 作者认为,关于这些手术功能结局的进一步研究可能有助于阐明PFR及其后续翻修的价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patellofemoral replacements (PFRs) have a higher rate of revision than unicompartmental knee arthroplasty or TKA. However, there is little information regarding why PFRs are revised, the components used for these revisions, or the outcome of the revision procedure. Some contend that PFR is a bridging procedure that can easily be revised to a TKA with similar results as a primary TKA; however, others dispute this suggestion. QUESTIONS/PURPOSES: (1) In the setting of a large national registry, what were the reasons for revision of PFR to TKA and was the level of TKA constraint used in the revision associated with a subsequent risk of rerevision? (2) Is the risk of revision of the TKA used to revise a PFR greater than the risk of revision after a primary TKA and greater than the risk of rerevision after revision TKA? METHODS: Data were obtained from the Australian Orthopaedic Association Joint Replacement Registry through December 31, 2016, for TKA revision procedures after PFR. Because revisions for infection may be staged procedures resulting in further planned operations, for the revision analyses, these were excluded. There were 3251 PFRs, 482 of which were revised to TKA during the 17-year study period. The risk of second revision was calculated using Kaplan-Meier estimates of survivorship for PFRs revised to TKAs, and that risk was compared with the risk of first revision after TKA and also with the risk of a second revision after revision TKA. Hazard ratios (HRs) from Cox proportional hazards models were used to compare second revision rates among the different levels of prosthesis constraint used in the index revision after PFR (specifically, cruciate-retaining versus cruciate-substituting). RESULTS: The main reasons for revising a PFR to TKA were progression of disease (56%), loosening (17%), and pain (12%). With the numbers available for analysis, there was no difference in the risk of a second revision when a PFR was revised to a cruciate-retaining TKA than when it was revised to a cruciate-substituting TKA (HR, 1.24 [0.65-2.36]; p = 0.512). A total of 204 (42%) of the PFR revisions had the patella component revised when the PFR was converted to a TKA. There difference in rates of second revision when the patella component was revised or not revised (HR, 1.01 [0.55-1.85]; p = 0.964). When we eliminated the devices that ceased to be used before 2005 (older devices), we found no change in the overall risk of repeat revision. The risk of a PFR that was revised to a TKA undergoing a second revision was greater than the risk of TKA undergoing a first revision (HR, 2.39 [1.77-3.24]; p < 0.001), but it was less than the risk of a revision TKA undergoing a second revision (HR, 0.60 [0.43-0.81]; p = 0.001). CONCLUSIONS: The risk of second revision when a PFR is revised is not altered if cruciate-retaining or posterior-stabilized TKA is used for the revision nor if the patella component is revised or not revised. The risk of repeat revision after revision of a PFR to a TKA was much higher than the risk of revision after a primary TKA, and these findings did not change when we analyzed only devices in use since 2005. When PFR is used for the management of isolated patellofemoral osteoarthritis, patients should be counselled not only about the high revision rate of the primary procedure, but also the revision rate after TKA. Further studies regarding the functional outcomes of these procedures may help clarify the value of PFRs and subsequent revisions. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Lewis PL, Graves SE, Cuthbert A, et al. What Is the Risk of Repeat Revision When Patellofemoral Replacement Is Revised to TKA? An Analysis of 482 Cases From a Large National Arthroplasty Registry. Clin Orthop Relat Res. 2019. PMID: 31136442. doi:10.1097/CORR.0000000000000541

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。